140 related articles for article (PubMed ID: 33042341)
41. Coexisting DCIS and phyllodes breast tumors in Young Chinese women: Case series.
Sun L; Zhu R; Ginter P; Malik M; Sung KJ; Hughes JM; Siegel B; Tsai J
Int J Surg Case Rep; 2019; 56():13-16. PubMed ID: 30798095
[TBL] [Abstract][Full Text] [Related]
42. Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis.
Sawalhi S; Al-Shatti M
Ann Saudi Med; 2013; 33(2):162-8. PubMed ID: 23563006
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathology and treatment of a giant malignant phyllodes tumor of the breast: A case report and literature review.
Warner WA; Sookdeo VD; Fortuné M; Akhilesh M; Rao Adidam Venkata C; Mohammed W; Ramkissoon C; Harnanan D; Pran L; Maharaj R
Int J Surg Case Rep; 2017; 41():259-264. PubMed ID: 29121581
[TBL] [Abstract][Full Text] [Related]
44. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
[TBL] [Abstract][Full Text] [Related]
45. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases.
Reinfuss M; Mituś J; Duda K; Stelmach A; Ryś J; Smolak K
Cancer; 1996 Mar; 77(5):910-6. PubMed ID: 8608483
[TBL] [Abstract][Full Text] [Related]
46. Re-Classification with Outcome Correlation of Previously Diagnosed Malignant Phyllodes Tumors Applying the 2016 Consensus Guidelines.
Duckworth LA; Hoda R; Komforti MK; Rowe JJ; Downs-Kelly E; McIntire PJ
Int J Surg Pathol; 2023 Aug; 31(5):557-563. PubMed ID: 35786083
[No Abstract] [Full Text] [Related]
47. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
[TBL] [Abstract][Full Text] [Related]
48. Unpredictable behavior of breast phyllodes tumors.
Akcakaya A; Koc B; Erozgen F; Memmi N; Hot S; Yildiz MK; Gucin Z; Adas G; Kemik O
Eur Rev Med Pharmacol Sci; 2014; 18(18):2655-61. PubMed ID: 25317800
[TBL] [Abstract][Full Text] [Related]
49. Margin Status and Local Recurrence in Phyllodes Tumours of the Breast: A Canadian Series.
Moldoveanu D; Iny E; Theriault C; Florea A; Wong SM; Basik M; Boileau JF; Margolese R; Pelmus M; Meterissian S; Prakash I
Ann Surg Oncol; 2023 Mar; 30(3):1700-1709. PubMed ID: 36456792
[TBL] [Abstract][Full Text] [Related]
50. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.
Zhang Y; Kleer CG
Arch Pathol Lab Med; 2016 Jul; 140(7):665-71. PubMed ID: 27362571
[TBL] [Abstract][Full Text] [Related]
51. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
[TBL] [Abstract][Full Text] [Related]
52. Phyllodes tumor of the breast: diagnosis, management and outcome during a 10-year experience.
Ditsatham C; Chongruksut W
Cancer Manag Res; 2019; 11():7805-7811. PubMed ID: 31695485
[TBL] [Abstract][Full Text] [Related]
53. Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study.
Lv S; Niu Y; Wei L; Liu Q; Wang X; Chen Y
Breast Cancer Res Treat; 2008 Dec; 112(3):411-8. PubMed ID: 18189161
[TBL] [Abstract][Full Text] [Related]
54. IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.
Bellezza G; Prosperi E; Del Sordo R; Colella R; Rulli A; Sidoni A
Int J Surg Pathol; 2016 Feb; 24(1):37-42. PubMed ID: 26353850
[TBL] [Abstract][Full Text] [Related]
55. Phyllodes Tumors of the Breast.
Abusalem OT; Al-Masri A
Mater Sociomed; 2011; 23(4):200-5. PubMed ID: 26664294
[TBL] [Abstract][Full Text] [Related]
56. Clinical Analysis of Phyllodes Tumor of the Breast.
Han SH; Lee WG; Cha KH; Lee TH; Shin DB; Ha SY; Park HG
Cancer Res Treat; 2001 Dec; 33(6):458-62. PubMed ID: 26680822
[TBL] [Abstract][Full Text] [Related]
57. Phyllodes Tumors-The Predictors and Detection of Recurrence.
Lim RS; Cordeiro E; Lau J; Lim A; Roberts A; Seely J
Can Assoc Radiol J; 2021 May; 72(2):251-257. PubMed ID: 32090614
[TBL] [Abstract][Full Text] [Related]
58. Factors effective on recurrence and metastasis in phyllodes tumors.
Altiok M; Kurt F
Niger J Clin Pract; 2022 Apr; 25(4):425-431. PubMed ID: 35439900
[TBL] [Abstract][Full Text] [Related]
59. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract][Full Text] [Related]
60. Repeat recurrence and malignant transition of phyllodes tumors of the breast.
Wada A; Hayashi N; Endo F; Tsunoda H; Yoshida A; Suzuki K; Nakamura S; Yamauchi H
Breast Cancer; 2018 Nov; 25(6):736-741. PubMed ID: 29951882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
